Comparative Efficacy and Safety of Daily Versus Alternate Day Dosing of Rosuvastatin in Dyslipidemic Patients: A Prospective, Randomized, Open Label Study. IJPRMH 2025, 1 (1), 10-19. https://doi.org/10.66328/ijprmh.2025.010103.